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Interest in the epidemiology of TB was triggered by the re-emergence of tuberculosis in the 
early 1990’s with the advent of HIV and falling economic status of many people which 
subjected them to poverty. The dual lethal combination of HIV and poverty triggered an 
unprecedented TB epidemic. In this study, we focused on the period 2000-2013 and all the 
notified data in Kenya was included. Data on estimates of TB incidence, prevalence and 
mortality was extracted from the WHO global Tuberculosis database. Data was analysed to 
produce trends for each of the years and descriptive statistics were calculated. The results 
showed that there was an average decline of 5% over the last 8 years with the highest 
decline being reported in the year 2012/13. TB continues to disproportionately affect the 
male gender with 58% being male and 42% being female. Kenya has made significant efforts 
to address the burden of HIV among TB patients with cotrimoxazole preventive therapy 
(CPT) uptake reaching 98% and ART at 74% by the end of 2013. Kenya’s TB epidemic has 
evolved over time and it has been characterised by a period where there was increase in the 
TB cases reaching a peak in the year 2007 after which there was a decline which began to 
accelerate in the year 2011. The gains in the decline of TB could be attributed in part to the 
outcomes of integrating TB and HIV services and these gains should be sustained. What is 
equally notable is the clear epidemiologic shift in age indicating reduced transmission in the 
younger age groups.  
 





Tuberculosis (TB) continues to be one of the major 
infectious diseases of public health concern globally 
WHO (2012). It is caused by bacillus bacteria and the 
most common causative organism is the 
Mycobacterium tuberculosis. Other causative agents 
that are occasionally implicated are Mycobacterium 
bovis which is transmitted through contaminated milk 
and Mycobacterium africanum, Cadmus et al. (2006). 
The transmission of the bacteria is through infectious 
aerosolized droplet nuclei generated by coughing, 
laughing, talking, sneezing and singing. The ability to 
generate infectious aerosolized droplet nuclei is 
dependent on the infectivity of the patient with sputum 
smear positive patients considered most infectious, 
Dooley et al. (1992). Infection with the mycobacterium 
does not always lead to development of disease as the 
immune system is able to contain the infection and the 
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The risk of infection is dependent on the extent to which 
exposure happens; longer durations of exposure to 
infected persons who are not on treatment increases 
the chance of infection, Dooley et al.(1992). The most 
at risk to develop TB include children under five, the old 
and those who are immunosuppressed, WHO (2012). 
Globally, the World Health Organization (WHO) 
estimates that 2 billion people, or 1/3 of the world’s 
population, are infected with (Mycobacterium 
tuberculosis) the bacillus that causes tuberculosis (TB). 
In 2013, there were 9 million incident cases with 1.5 
million people dying of TB, making it the leading 
infectious cause of death worldwide, WHO (2014). 
 
Globally, the African region contributes 26% of the  TB 
burden making the region the second after Asia which 
contributes 59% of the Global case load, WHO (2012). 
Kenya is among the twenty two (22) TB high burden 
countries in the world which contribute 80% of the 
global TB burden, WHO (2012). The absolute number 
of TB cases notified has increased more than tenfold 
since 1990 while the TB incidence has increased from 
below 50 per 100,000 in 1990 to 329 per 100,000 
population for all forms of TB in 2008, DLTLD (2013). 
The HIV epidemic is the single most contributing factor 
for this massive increase in the burden of TB in Kenya. 
From the Kenya AIDS Indicator Survey 2013, the 
prevalence of HIV in Kenya currently stands at 5.6%, 
NASCOP (2013), while the TB HIV co-infection rate 
was at 35% in 2014, NLTLD (2014). To combat the 
challenges of TB epidemic in Kenya there has been 
massive scale up of both treatment and diagnostic 
facilities. In 2013, diagnosis and treatment of TB was 
carried out by general health care workers in 1,900 TB 
diagnostic centres and over 4,300 TB treatment centres 
in Kenya DLTLD (2013). This translates to one 
diagnostic centre per 37,634 populations and one 
treatment centre per 18,411 populations DLTLD (2013). 
Diagnosis of TB is through sputum smear microscopy 
for new smear positive cases. Smear negative cases 
are diagnosed via a diagnostic algorithm as per the 
national TB guidelines DLTLD (2013). The diagnosis of 
extra pulmonary TB is based on clinical suspicion and 
the collection of appropriate specimens for TB 
bacteriology where this is feasible DLTLD (2013). 
Kenya developed a medium term TB control strategic 
plan covering the period 2011-2015 which is modelled 
along the WHO Stop TB Strategy. The global targets of 
TB control are to achieve at least 70% TB case 
detection rate and 85% treatment success rate, WHO 
(2006).  
 
Kenya has made good progress in the fight against TB; 
TB Case detection rate (CDR) reached 79% in 2013, 
the treatment success rate was 89% in 2013. By the 
end of 2014, 95% of TB patients were tested for HIV 
against a national target of 95%, NTLD (2014). Despite 
this progress, major problems still remain as close to  
21% of all incident TB cases are not detected, the 
significant delays in TB diagnosis facilitates TB 
transmission and is associated with a higher frequency 
of the poor sequel of TB and the emerging problem of 
drug resistant tuberculosis DLTLD (2013). There are 
concerns that inadequate infection control measures in 
health care settings may be facilitating the transmission 
of TB to health care workers and patients which has 
significant consequences for vulnerable groups such as 
HIV infected persons, DLTLD (2013). The emergence 
of multidrug-resistant Mycobacterium tuberculosis 
(MDR-TB) worldwide poses a serious problem to the 
treatment of tuberculosis. These MDR strains are at 
least resistant to two most important primary 
chemotherapeutic agents rifampicin and isoniazid, 
WHO (2003) which require treatment with more costly 
and more toxic second-line drugs. 
 
To understand TB epidemiology, there is need to 
consider the changes in the trends of the burden of TB 
disease over a period of time. The main indicators for 
the burden of TB disease include; incidence, 
prevalence and mortality, WHO (2013). These 
estimates have been derived from WHO databases on 
TB. Data on TB prevalence and mortality are hardly 
available due to low coverage of the civil registration 
systems in the country. Kenya is currently (2015) 
undertaking a TB national prevalence survey (the last 
TB prevalence survey was conducted in 1956). 
There is currently no nationally representative vital 
registration system with standard ICD-10 coding in 
place in Kenya. Less than half of deaths are recorded, 
and approximately 10% of deaths receive any ICD code 
(CRS, 2014). Results from a prevalence survey and 
vital registration systems can be used to assess the 
current levels of TB disease and mortality and could 
also provide important evidence about the effectiveness 
of current TB programmatic efforts and actions needed 
to improve TB care and control. 
 
Sitienei et al. (2013) has noted that the evolution of TB 
epidemiology in Kenya has mainly been guided by a 
number of factors which include but not limited to 
economic and environmental factors and the 
comprehensive TB control strategies that have been 
implemented by the Government of Kenya.  
In this paper we describe the epidemiological evolution 
of TB in Kenya over the last 14 years with focus of TB 
burden measures; prevalence, incidence, mortality and 
notifications over the years.   
 
 
MATERIALS AND METHODS 
 
This study was carried out through detailed and 
extensive review of existing TB/HIV data estimates 
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from the Global TB database 
(http://who.int/tb/country/data/download/en/). This data 
was further augmented from the National TB control 
program databases. The Kenyan National TB control 
program is well known for maintaining a robust 
surveillance system which maintains data on 
notification from the whole country. The Country has 
consistently reported the surveillance data to the World 
Health Organization which then facilitates the 
production of yearly country profiles.  
 
The national TB surveillance system in Kenya (TIBU)   
is an electronic case based system that enables 
availability of  real time information on all TB patients in 
the Country.  Data is entered into a tablet  by sub-
County TB coordinators from TB facility registers during 
routine monthly support supervision visits in the health 
facilities. The data is then electronically transmitted to 
the national database. This electronic system 
commenced in 2012, replacing the previous paper 
based system where the districts would on a quarterly 
basis aggregate all data from health facilities before 
transmission to the regional and national levels.  
After retrospectively extracting the data from the Global 
WHO database on estimates of prevalence, incidence 
and mortality together with the notification data from the 
National TB databases for the period (2000-2013), the 
data was subjected to exploratory data analysis (EDA) 
to look at the emerging trends that was inherent in the 
data. The datasets that did not have all the requisite 
variables were omitted from the analysis. The data was 
managed using MS access and excel was used to 
create graphs and tables to depict the changes in TB 
epidemiology over the years.  
The trends in case notification rates were obtained 
using total TB cases notified and population estimates 
from the Kenya National Bureau of statistics. The data 
was stratified by year, child/adult (<14 years and >15 
years), gender, HIV test, disease type and age group.  
 
In Kenya, the policy for diagnosis of TB is that, all 
presumed TB cases with signs and symptoms of TB 
are sent to the laboratory for collection of sputum 
specimen and examination in the laboratory for 
presence or absence of tubercle bacilli. Those whose 
specimens turn positive for tubercle bacilli are classified 
as smear positive, while those who are smear negative 
may be commenced on treatment if they fit the clinical 
diagnostic criteria or having been diagnosed for TB 
based on an abnormal  chest x-ray. Before the patients 
are started on TB treatment, patients are provided with 
information and advantages of HIV testing and those 
who consent are provided with HIV testing according to 
the national guidelines. Further treatment and diagnosis 
for Tuberculosis in Kenya is free and the government 
bears the costs of both diagnosis and procurement of 
quality assured anti TB medicines. 
RESULTS  
 
Burden of TB Disease 
 
Burden of disease is looked at from 3 contexts; 
incidence, prevalence and mortality. Analysis of the 
trends in estimates of TB incidence (Figure 1) suggests 
a consistent decline in new TB cases over time, with 
the decline in TB cases starting in 2005 following the 
decline in TB/HIV cases which started in 2004. After 
peaking in 2006, there has been a slowing in the rate of 
decline in estimates of TB prevalence (Figure 2). TB 
mortality estimates suggest an increase in TB deaths in 
2011-2012 (Figure 3). However, the wide confidence 
intervals indicate considerable uncertainty in the 
estimates, suggesting the need for other more direct 
methods to measure prevalence and mortality.  
With regards to deaths occurring to HIV positive TB 
patients there has been a consistent decline in the 
estimated TB-related deaths among people living with 
HIV (Figure 4). This could be attributed to interventions 
in both HIV and TB programs beginning to bear fruits 
and could need to be further sustained. 
 
TB Case Notifications 
 
In Kenya, the number of notified TB cases (all forms) 
increased from approximately 95,000 cases in 2003 to 
a peak of over 116,000 cases in 2007 (Figure 5). After 
2007, the number of notified TB cases steadily declined 
until 2013, when the number of notified TB cases was 
approximately 89,000 – the lowest it has been in over a 
decade. Approximately 10,000 fewer cases were 
reported in 2013 compared with 2012. This trend is 
consistent with the trend of incidence and prevalence 
which has been observed in (Figures 1 & 2) above. 
The case notification rate for all TB cases (new and 
retreatment) shows three distinct trends (Figure 6). 
From 2000 to 2004, the TB case notification rate 
increased steadily; from 2004 to 2006, rates remained 
constant; and from 2006 to 2013, rates steadily 
declined, with rates in 2013 lower than those recorded 
in 2000 (Figure 6). Based on national data, the case 
notification rates fell especially quickly between 2011 
and 2013, decreasing approximately 8% and 12% each 
year, respectively (Table 1); for all years, notification 
rates based on Kenyan data are slightly higher than 
WHO estimates (Figure 6) and this may be explained 
by use of different population estimates. 
 
Case notification rates were calculated using population 
estimates from Kenya’s 2009 census (years 2009-
2013) and updated population estimates from the 1999 
census (years 2003-2008). Changes in population 
estimates between 2008 and 2009 did not appear to 
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Figure 3. Tuberculosis mortality 2000-2012 
 
 
As shown in Figure 7, the percentage of new childhood 
and adult TB cases has remained consistent between 
2008 – 2012.The ratios are fairly consistent with the 
rates that have been proposed by WHO in their 
standards and benchmarks tool which suggests that the 
data collected at the national level have a high level of 
external consistency if the percentage of children 
diagnosed with TB ranges between 5-15% in low - and 
middle-income countries, WHO (2014). 
 
TB Cases by Disease Type  
 
The relative numbers of new bacteriologically confirmed 
(smear positive) cases and extrapulmonary TB cases 
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Figure 6. TB notification rates: 2000-2012 
 
 
have remained fairly consistent over time (Figure 8). 
The percentage of new cases that are bacteriologically 
confirmed ranged from 37.3% to 43.0% between 2003 
to 2012, fluctuating slightly from year-to-year. The 
percent of new cases that are extrapulmonary, 
however, increased gradually since 2003 but 
maintained a narrower range: 15.1% to 18.2% (Figure 
8). This slight increase may result in a reduction in TB 
transmission because there are fewer pulmonary TB 
cases in the community. Further, when smear positive 
new cases are compared to extrapulmonary TB, it 
shows that the percentage range of extra-pulmonary is 
between 26% and 31% over the years and has 
remained stable in this range (Figure 9).  
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Table 1. Change in Notified TB cases (all 
forms), Kenya, 2003-2012 
 
Year 
National TB case 
notification rate (per 
100,000) 
% Δ from 
previous 
year 
2000 210.8   
2001 233.2 10.6% 
2002 254.8 9.3% 
2003 287.3 12.7% 
2004 309.6 7.8% 
2005 308.5 -0.4% 
2006 318.7 3.3% 
2007 313.9 -1.5% 
2008 288.0 -8.2% 
2009 281.2 -2.4% 
2010 263.6 -6.2% 
2011 251.0 -4.8% 
2012 230.9 -8.0% 
2013 203.1 -12.1% 
 





Figure 8. Percent of new bacteriologically confirmed (smear positive) and extrapulmonary TB cases out of all new cases, 
Kenya, 2003 – 2012. 
 
 
TB Cases by Age  
 
The largest number of TB cases occurred among 
young adults (Figure 10), with the most cases reported 
for adults aged 25-34 years, followed by adults aged 
35-44 and 15-24 years; this indicates that HIV 
continues to be a major driver of the TB epidemic in 
Kenya. The average age of TB cases in 2012 and 2013 
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Figure 10. All TB cases by age group- Kenya, 2008-2012 
 
 
was 33.7 and 37.7 years, respectively; these are the 
only years for which case-based data are available.  
The fewest cases were reported in children aged 0-4 
years.   
 
 
Age- and sex-specific case notification rates 
 
Figures 11a and 11b show that among all age groups, 
except for children (0-15 years) and young adults (15-
24 years), males had higher TB case notification rates 
than females. For children and young adults, rates of 
new TB disease were equal between males and 
females.  For both males and females, adults aged 35-
44 years had the highest rates of new TB disease; 
however, rates of TB among males in this age group 
were approximately 30% greater than rates of TB for 
females in the age group.  
Differences between males and females by age group 
remain, but are less pronounced for new smear positive 
TB case notification rates (Figures 12a and 12b). In 
particular, for males, 35-44 and 25-34 year olds have 
the highest rates for smear positive TB, while 35-44 
and 45-54 year olds have the highest rates for all forms 
of new TB. 
Overtime there has been a small decrease in case 
notification rates for all new cases and all new smear 
positive cases for both males and females (Figures 11a 
and 11b, 12a and 12b). Children and young adults (15-
24 years) saw the most minimal change over time. 
Adult’s aged 64 years and above were the only group 
to experience increases in TB cases rates.  
From the age sex distribution (figures 13-16), it is clear 
the most vulnerable age group is that of 15-44, the most 
vulnerable group being those aged 15 to 44 the most 
economically  productive   segment  of   the  population.
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Figures 12a and 12b. New smear positive case notification rates per 100,000 among males and females in Kenya from 2003 – 
2012. 
 
It further shows that those mostly affected are in the 
age group 25-34 years. Interesting observation though 
is depicted in (figure 13) which shows that there is a bi- 
modal peak at age 15 and 25 years of age amongst the 
female smear positive TB cases. 
 
National-level TB data disaggregated by age (Figures 
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Figure 15. Distribution all forms of TB for females per age group 
 
 
the elderly (≥64) has been consistently lower than rates 
among middle-aged adult males or females (i.e., 35-44 
and 45-54 age groups), it has gradually increased while 
rates in younger groups have declined. 
 
TB in High Risk Groups 
 
In  Kenya,  data  on  TB  in  high  risk groups are largely 
available only about persons living with HIV/AIDS. HIV 
remains the predominant risk factor for developing TB 
in Kenya. The TB programme has continued to 
successfully test more TB cases for HIV over time. 
Although rates of HIV remain high among persons with 
TB who know their status, more than one-third of TB 
cases have HIV,  HIV prevalence among TB cases has 
been decreasing (Figure 17).  There has been 
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Figure 17. The percentage of TB cases who are tested for HIV, and the percentage of TB cases tested for HIV who are 





Figure 18. CPT and ART uptake in Kenya 2005-2012 
 
 
significant effort to reduce the burden of HIV among TB 
patients through the implementation of TB/HIV 
collaborative interventions with the main focus being 
provision of CPT and ART to HIV positive TB patients. 
There has been significant increase in CPT uptake from 
44% in 2005 to 97% by the end of 2012 while ART 
uptake increased form a low figure of 17% in 2005 to 
74% by the end of 2012 (Figure 18). 
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The burden of TB disease in Kenya has shown 
consistent decline in the last 8 years. This result is 
consistent with the findings by Sitienei et al. (2013). 
The key disease burden measures incidence, 
prevalence and mortality has shown marked decline 
over the last couple of years, however, prevalence and 
mortality have high levels of uncertainty WHO (2012). 
Although mortality estimates have high levels of 
uncertainty, there has been marked decline in the 
estimates of TB deaths among the HIV patients. This in 
part could be attributed to high HIV testing and initiation 
of ART treatment among HIV positive patients WHO 
(2012). 
It is expected that with a robust surveillance system, 
notifications should provide good approximations to TB 
incidence DLTLD (2013). Kenya over the last 14 years 
has notified cumulatively 1,378,592 TB cases DLTLD 
(2013). Year by year trend has shown that Kenyan TB 
epidemic peaked in the year 2007 and has been on a 
decline since then with an average decline of 5% over 
the last 8 years. The highest decline in the TB case 
notification was reported between the years 2012-2013 
at 12%. There has been consistent trend in the case 
notification rates from both the Kenyan TB data and 
WHO estimates DLTLD (2013). 
In this paper, it has been further demonstrated that the 
proportion of childhood TB has remained fairly 
consistent over the years. With more attention currently 
being directed at childhood TB through better 
diagnostic tools and improvement of surveillance 
systems it could reduce the gap in understanding 
childhood TB epidemiology, (Glaziou et al. (2015), 
WHO (2013)).  
In Kenya, a large proportion of TB has been those who 
have been confirmed to have TB using smear 
microscopy examination with this proportion ranging 
(37-43) %,  the extra-pulmonary ranges from (15-18)% 
and the smear negative TB cases ranging between (33-
42)%.  
 
Kenya began the disaggregated reporting for age and 
sex in the year 2008, while adopting the case based 
surveillance system in the year 2012 DLTLD (2013). 
The disaggregation has clearly shown that tuberculosis 
continues to take greater toll on those in the age groups 
25-44 years, this being the most economically 
productive group. The average age of a TB patient has 
increased from 33.7 to 37.7 between the year 2012 and 
2013. Fewer children aged 0-4 years have consistently 
been reported to have tuberculosis.  
From the age sex case notification rates it can be seen 
that tuberculosis continues to be a male disease with 
rates in males being approximately 1.5 times higher 
than in female in the most productive age groups 25-64 
years. This trend is similar for both all forms of TB and 
smear positive. It was however, noted that the age sex 
distribution for smear positive TB was bimodal for 
females while unimodal for males. This result is 
consistent with results in Sitienei et al. (2013). 
However, for all forms of TB the peakedness of the 
distribution is unimodal at the same age groups 25-34 
years. At present there is no plausible explanation for 
the difference in the age sex distribution peakedness 
for smear positive TB Sitienei et al. (2013). It can 
however be hypothesized that it could be because of 
early sexual activity in female which predisposes them 
to HIV and consequently tuberculosis. There is thus 
need for further studies to explain the difference. Other 
possible hypothesis that have been advanced include 
biological differences in the risk of infection and 
subsequent TB disease Thorson et al. (2007), 
differences due to gender roles in different communities 
which predisposes men to TB disease (Borgdorff et al. 
(2000), Connolly and Nunn (1996)) and the hypothesis 
that it could be that women access services to a greater 
extent than men in some settings or that disease 
progression could be slower on average in women 
Glaziou et al. (2015). 
 
Sitienei et al (2013) showed that HIV is the single most 
important factor that caused resurgence of TB in Kenya 
and there is a twin relationship between HIV and TB. 
This historical twin relationship has been shown by 
K’Oyugi and Muita (2002). To understand TB 
epidemiology in Kenya, understanding the close 
relationship between TB and HIV is critical. The data 
from the surveillance system show that upon the 
adoption in Kenya of the WHO interim policy on TB/HIV 
collaborative activities in 2004, WHO (2004) with Kenya 
adopting the policy in 2005. The HIV testing rose from 
83 to 94% with HIV sero prevalence declining from 45% 
to 38% by the end of 2012. It had further been shown 
that those countries with high HIV prevalence have also 
high burden of TB. Narain and Lo (2004). Given the 
role HIV plays in the development of TB disease 
provision of ART and isoniazid (INH) prophylaxis has 
increasingly played the role in the prevention of TB in 
individuals with HIV and latent TB infection. (Glaziou et 
al. 2015, Straetemans et al. 2010, Glaziou et al. 2011). 
Kenya has made significant strides in addressing the 
dual burden with 74% of the HIV positive TB patients 
accessing ART within TB clinics free of charge from the 
government by the end of 2012 DLTLD (2013). 
The association between poverty and tuberculosis has 
been well established and widespread in literature of 
TB risk factors. It has been shown that TB prevalence 
is significantly higher among people living below the 
poverty line compared with those above the poverty line 
and the situation is even more dire among the 
marginalised people, where TB could be 1.5 times 
more prevalent Muniyandi and Ramachandran (2008). 
Further, it has been shown that TB can contribute to 
moving individuals into poverty by reducing patients’ 
physical  strength and ability to carry on normal routine 
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work (Patton and Ng, 2006; Sagbakken, 2008; WHO, 





Kenya’s TB epidemiology has evolved over time and it 
has been characterised by a period where there was 
increase in the TB cases reaching a peak in the year 
2007 after which there was a decline which began to 
accelerate in the year 2011.  The gains which have 
been witnessed should be sustained. What is equally 
notable is the clear epidemiologic shift in age indicating 
reduced transmission in the younger age groups. 
All indications are that the TB epidemic in Kenya is on a 
downward trend and the country is on course to halting 
the beginning to reverse the effects that the epidemic 
has caused.  
To sustain the gains made in containing TB in Kenya, 
efforts must also be made in addressing the risk factors 
majorly HIV and what has been demonstrated that the 
burden of HIV on TB patients has been addressed in 
the country but focus should be on universal access to 
ART for those who are eligible and access to the INH 
prophylaxis.  
Further, to sustain the gains social determinants in 
health must be addressed given that TB affects the 
most vulnerable in the population and should include 
strengthening partnership across all the sectors that are 
involved. Further systematic analysis should be carried 
out to understand the socio economic dynamics of TB 
patients in order to address the well-being of the TB 
patients.  Kenya is on course to achievement of 
millennium development goals (MDGs) of halting and 
beginning to reverse the incidence and prevalence to 
tuberculosis.  
To better understand mortality, greater focus should be 
given to improvement of mortality statistics though 
strengthening of collaboration with the civil registration 
system in the country and supporting the improvement 
in the capacity to certify and code cause of death in 
health facilities and consider initiation of verbal 
autopsies to obtain an understanding of cause of death 
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